Chemoinformaics analysis of (2S,4R)-2-AMINO-6-(DIAMINOMETHYLIDENEAMINO)-4-HYDROXYHEXANOIC ACID
| Molecular Weight | 204.23 | nRot | 6 |
| Heavy Atom Molecular Weight | 188.102 | nRig | 0 |
| Exact Molecular Weight | 204.122 | nRing | 0 |
| Solubility: LogS | -0.75 | nHRing | 0 |
| Solubility: LogP | 1.379 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 4 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 4 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 29.1647 |
| nHD | 5 | BPOL | 16.3493 |
| QED | 0.513 |
| Synth | 1.566 |
| Natural Product Likeliness | 1.073 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.07 |
| HIA | 0.004 |
| CACO-2 | -4.143 |
| MDCK | 0.0000283 |
| BBB | 0.99 |
| PPB | 0.320315 |
| VDSS | 0.937 |
| FU | 0.679589 |
| CYP1A2-inh | 0.494 |
| CYP1A2-sub | 0.817 |
| CYP2c19-inh | 0.048 |
| CYP2c19-sub | 0.488 |
| CYP2c9-inh | 0.023 |
| CYP2c9-sub | 0.434 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.134 |
| CYP3a4-inh | 0.009 |
| CYP3a4-sub | 0.146 |
| CL | 8.981 |
| T12 | 0.798 |
| hERG | 0.032 |
| Ames | 0.009 |
| ROA | 0.129 |
| SkinSen | 0.478 |
| Carcinogencity | 0.311 |
| EI | 0.993 |
| Respiratory | 0.045 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.859012 |